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An accelerated atherosclerosis, in particular of the cor-
onary arteries, was documented in hypertriglyceri-
demia. The objective of the present study was to assess 
the cutaneous dynamic blood flow in hypertriglyceri-
de mia, utilizing the optical noninvasive method of 
laser Doppler flowmetry. The cutaneous blood flow on 
the forearms was measured during the postischemic 
reactive hyperemia test in treated and non-treated 
patients with hypertriglyceridemia and healthy con-
trol subjects. The subjects were 32 patients with 
hypertriglyceridemia -15 untreated and 17 follow-
ing 6-9 months of bezafibrate treatment-and 27 
healthy control subjects. 
In untreated patients with hypertriglyceridemia, the 
peak flow was significantly lower than in both the 
treated group (p < 0.005) and control group (p < 0.02). 
Similarly, the area under the response-time curve of 
the untreated patients with hypertriglyceridemia was 
smaller (p < 0.01 and p < 0.05, respectively). These 
parameters were similar in the treated group and the 
A therosclerosis and ischemic heart disease may be in-duced by high plasma cholesterol levels, but the asso-ciation of these conditions with hypertriglyceridemia (HTG) is still controversial. In recent years, however, an increasing number of reports have shown an accel-
erated atherosclerosis, in particular of the coronary arteries, in pa-
tients with HTG [1,2]. Such an occurrence bears great importance 
because HTG is the most common hyperlipidemia [1,3], and tri-
glyceride-lowering therapy (diets and drugs) is effective. Abnormal 
interactions between triglycerides (TG) and endothelial cells in vivo 
might generate an accelerated atherosclerosis in the presence of 
high plasma TG levels. Thus, Gianturco et al [4] demonstrated that 
with high levels ofTG abnormal lipoproteins accumulate and bring 
about atherogenic changes in vitro. Other in vitro and ill vivo studies 
showed additional pathologic changes in HTG. Such is the study by 
Gianturco et al [5]. who found that in HTG two-thirds of very 
low-density lipoprotein (VLDL) apo-B disappears directly from the 
plasma, whereas it is first converted to low-density lipoprotein 
(LDL) in healthy subjects. Finally, some forms of HTG, such as 
HTG secondary to a kidney disease, or familial combined hyperli-
poproteinemia, are known to be associated with accelerated athero-
sclerosis [1,3,5]. 
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control group. The reaction was faster in the treated 
group, as compared to the other two groups (p < 
0.001). The control group exhibited a longer time to 
decay than the treated group (p < 0.01). 
Postischemic reactive hyperemia tests in patients 
with hypertriglyceridemia reveal cutaneous microcir-
culatory changes in the forearm. These changes may 
arise from several mechanisms, including functional 
abnormalities of the endothelium or vascular smooth 
muscle, or structural changes in the blood vessels that 
limit vasodilatation. These changes are reversible, and 
corrected when reducing the triglyceride levels, but 
other abnormalities are then present, suggesting a per-
manent damage. These dynamic measurements of cu-
taneous blood flow are sensitive indicators of athero-
genesis, and can be employed for the evaluation of 
microvascular involvement and follow-up of patients 
with hypertriglyceridemia. Key words: laser Doppler 
jlowmetry / cutaneous postischem ic reactive hyperemia /beza-
fibrate. ] Invest Dermato1103:597 - 600, 1994 
Atherosclerosis may be reflected in the skin microcirculation, 
which is readily accessible. Noninvasive examination of the skin 
microcirculation may present evidence even for profound vascular 
diseases, such as atherosclerosis. In particular, laser Doppler flow-
metry (LDF) is an optical method of evaluating the blood flow in 
the microcirculation of the skin (to a depth of 1.5 mm) [6-11]. In 
addition to baseline blood flow measurements, the timecourse of the 
cutaneous response to postischemic reactive hyperemia test, when 
studied by LDF, can provide accurate and detailed information 
about changes in the microcirculation [7 - 11], because it reveals 
information about the hemodynamics of the limb, including the 
ability to respond to an arrest in the circulation and to compensate 
for it. The cutaneous postischemic reactive hyperemia test increases 
the sensitivity of the measurement and provides a higher level of 
differentiation between different phases of the obstructive disease in 
the blood vessels [12]. Cutaneous postischemic reactive hyperemia 
is an increased blood flow to a tissue, limb, or organ that follows the 
release of a brief obstruction. The increase of blood flow rapidly 
disappears and returns to normal levels within a few minutes. Com-
bined with LDF, cutaneous postischemic reactive hyperemia was 
used to detect differences between smokers and nonsmokers [8], and 
between diabetic patients and controls, as well as between subgroups 
of diabetic patients [9]. Provocative studies of this type were also 
successfully conducted in patients with peripheral vascular dis-
ease [12], as well as other static and dynamic studies utilizing LDF 
[13-15]. 
The aim of the present study was to assess the cutaneous dynamic 
blood flow abnormalities in HTG, and to determine whether only 
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Table I. Values of Hemoglobin, Platelets, Triglycerides, and Cholesterol in the Three Groups· 
Group 
HTG 
Post-HTG 
Control 
Statistical differences 
• V alues arc means ± so. 
b NS. non-significant. 
Number of 
Subjects 
15 
17 
27 
Hemoglobin 
(g/dl) 
15.3 ± 0.9 
15.2 ± 1 
15.1 ± 1 
NSb 
rheologic factors are involved or permanent damage exists. The 
plan of the study was to compare the cutaneous response to ischemia 
in the forearms of treated and non-treated HTG patients with that 
of healthy control subjects. 
MATERIALS AND METHODS 
Patients The subject pool comprised 59 subjects in three groups. Group 1 
was a hypertriglyceridemic group of 15 subjects (nine male, six female), 
average age 47.06 years (SD 9.68, range 29 - 69 years), with mean TG serum 
levels of748 mg/dl (SD 294). According to a recent classification (16], this is 
a high - TG-Ieve!s group (normal TG levels are defined as lower than 200 
mg/dl; borderline levels, 200-400 mg/dl; high levels, 400-1000 mg/dl; 
and very high levels, over 1000). The average duration ofHTG was 3.9 years 
(SD 2.3). Two were smokers. Group 2 was a hypertriglyceridemic group 
examined after lowering the TG levels to 276 mg/dl (SD 104) following 
6 - 9 months of bezafibrate 400 mg/day treatment. This group included 17 
subjects (11 male, six female), average age 50.07 years (SD 12.64, range 
36-77 years). The average duration ofHTG was 3.8 years (SD 2.1). Three 
were smokers. Group 3 was a healthy control group of27 subjects (15 male, 
12 female) with an average age of 45.06 years (SD 15, range 29-68 years), 
and mean serum TG levels of89 (SD 28) of whom five were smokers. None 
of the controls or HTG subjects were taking drugs with a known action on 
the blood vessels at the time of investigation, apart from bezafibrate in the 
treated HTG group. None of the subjects had diabetes or hypertension. 
The values of. hemoglobin, platelets, TG, and cholesterol in the three 
groups are given in Table I. The patients were referred from dermatology 
and metabolic outpatient clinics. The subjects gave informed consent for the 
study, the protocol of which was approved by the Israeli Ministry of Health 
Committee for the Conduct of Human Research. A thorough medical his-
tory was taken and physical examination performed on all subjects. 
Cutaneous Postischemic Reactive Hyperemia Test The cutaneous 
postischemic reactive hyperemia test was performed on the forearms where 
arterioles, capable of reactive hyperemia, are abundant. The ventral forearm 
is a site of relatively low blood flow, and in this way, the mag~itude of the 
changes induced by this vasodilative test is maximized. Indeed, quite a few 
diseases and conditions were successfully investigated by LDF studies of 
forearm-based postischemic reactive hyperemia [6,8,9] . The basic flow was 
recorded for 5 min in the middle of the flexor aspect of both forearms. The 
arm was then clamped in a pneumatic cuff and inflated to 300 mm Hg for a 
period of 4 min during which blood flow measurements were continuously 
recorded. The cuff was then deflated instantaneously and recording was 
continued for an additional period of 4 min. Measurements were taken on 
both forearms in the flexor aspect. 
Cutaneous Microvascular Blood Flow Measurements A laser 
Doppler flowmeter (Periflux PF2, Perimed, Sweden), was utilized. The 
principles underlying laser Doppler flowmetry have been described else-
where [6 - 15]. The deprh of penetration of the light into the skin is about 1 
mm. The instrument was adjusted to a bandwidth of 4 kHz and output gain 
of 10. The integrator was set at a high value to smooth out fluctuations due 
to the cardiac cycle. A probe holder (PF 104, Perimed, Sweden) was posi-
tioned over the test site and held in place with double adhesive discs (3M, 
MN) . The timecourse of the cutaneous flow was recorded. and the baseline 
value subtracted before further processing. The following parameters were 
measured: P = peak flow above rest flow; Tp = time required to reach the 
peak flow; A is the area below the time response curve; and Td is the time to 
decay to the baseline flow. 
All measurements were done in the same room, at 21 ± 1.5°C. Prior to 
the experiment the patients were allowed 20 min of acclimatization. 
Statistical Methods Comparisons between the parameters measured in 
the three groups involved the Kruskal-Wallis non parametric tesr followed 
by the Mann-Whitney U test for comparing the different pairs. 
Platelets Triglycerides Cholesterol 
(X W/I) (mg/dl) (mg/dl) 
232 ± 48 748 ± 294 247 ± 47 
219±50 276 ± 104 226 ± 43 
242 ± 52 89 ± 28 211 ± 31 
NS P < 0.01 NS 
RESULTS 
Table IT and Fig 1 summarize the results of the cutaneous postis-
chemic reactive hyperemia test in treated and untreated HTG pa-
tients as compared to healthy controls . Figure 1 is a box plot [17] of 
the measured parameters in the three groups. Significant differences 
were observed among the three groups. The reaction in the treated 
group was faster than in the other two groups; the time required to 
reach the peak (Tp) was shorter in the treated group than both HTG 
and control groups (p < 0.001), which did not significantly differ 
from each other. The peak flow (P) was lower in the HTG group 
than in both the treated (p < 0.005) and control groups (p < 0.02), 
and the area under the response-time curve of the HTG was also 
smaller than the other groups (p < 0.01 and p < 0.05, respectively), 
whereas the latter two groups did not differ significantly from each 
other. The time to decay (Td) was longer in the control group than 
in the treated group (p < 0 .01) . 
DISCUSSION 
Our results indicate that there are functional microvascular distur-
bances in the forearm skin ofHTG patients. Increased blood viscos-
ity alone or in combination with functiona l or structural vascular 
changes might have produced these abnormalities. There are several 
mechanisms possibly involved in the observed abnormal microvas-
cular response. 1) The elevated TG levels increase blood viscosity 
and this in turn decreases cutaneous blood flow. Wilkin [18] has 
demonstrated that viscoelastic factors determine the configuration 
of the cutaneous reactive hyperemic response. 2) A failure of maxi-
mal vasodilatation at the precapillary sphincter muscle level or sym-
pathetic denervation may be involved in the impaired reactive hy-
peremia response [9] . An indication of such a possibility is the 
adverse effect of HTG on neuronal membrane metabolism [19]. 
This neuropathy is reversible when the lipid levels are normalized, 
which explains the improvement in the impaired reactive hypere-
mia response following therapy. 
The third possibility is that enhanced atherogenesis in skin blood 
vessels might occur in HTG, similar to coronary arteries, resulting 
in decreased perfusion and an impaired reactive hyperemia response. 
If thickening of small arteries and arterioles takes place in HTG, it 
may lessen the vessel wall compliance and reduce its ability to re-
spond to fast changes. Similarly, in patients with peripheral occlu-
sive arterial disease, peak flow was lower than in normal subjects 
[10] . 4) Endothelial damage may create the observed abnormalities, 
as enzymatic or mechanical removal of the endothelia of segments 
of arterioles in vitro prevented the reactive hyperemia response [20]. 
Likewise, a lower maximum reactive hyperemia response was regis-
tered right after smoking a cigarette, which creates endothelial 
damage [8]. 
A treatment of 6 - 9 months resulted in a significant improvement 
in skin blood flow. Structural blood vessel changes are possible due 
to a modification of the atherosclerotic plaques. Likewise, Rogers et 
aJ [19] achieved an improvement in cerebral perfusion in 4-6 
months. Rheologic changes occurred much faster, whereas im-
provement in perfusion was not yet achieved. Therefore, their study 
suggests that the improvement in cerebral perfusion following 
therapy was due to a reversal of cerebral atherosclerosis rather than 
improvement in blood rheology and membrane metabolism. The 
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Table II. Cutaneous Response to Postischemic Reactive Hyperemia Test as Measured by Laser Doppler Flowmetry in 
Treated and Non-Treated HTG Patients and Healthy Controls·,b 
Group Number p' T p(min)d A' Td (miny 
HTG 15 9.49 ± 1.0 0.296 ± 0.03 6.78 ± 1.0 2.3 ± 0.30 
Post-HTG 17 15.82 ± 1.3 0.174 ± 0.02 9.98 ± 1.2 1.9 ± 0.18 
Control 27 12.94 ± 0.9 0.306 ± 0.01 13.40 ± 1.6 2.9 ± 0.27 
• Values are means ± SEM. The results are averages of both forearms. The LDF readings are expressed in arbitrary units . 
• HTG, hypertriglyceridemia; post-HTG, post treatment for hypertriglyceridemia; P, peak; Tp, time to peak; A, area under the curve; Td, time to decay. 
, HTG lower than both post.HTG (p < 0.005) and control (p < 0.02). 
'Post-HTG shorter than both HTG and control (p < 0.001). 
, HTG lower than both post-HTG (p < 0.05) and control (p < 0.01). 
J Control longer than post-HTG (p < 0.01). 
lowering of TG levels did not achieve a complete recovery of skin 
blood flow in our treated patients, as demonstrated by a shorter time 
to decay of the reactive hyperemia response. The shorter time 
needed to reach the peak of the response might represent a compen-
satory mechanism for correcting the overall response. Additionally, 
bezafibrate reduces plasma fibrino gen concentration, which lowers 
blood viscosity and platelet aggregation and increases blood filtera-
bility [21 J. Thus, it improves the hemorheologic pattern, as re-
flected in the blood flow measurements. 
Measurements of cerebral blood flow were more sensitive as an 
indicator of atherogenesis of cerebral vessel s than clinical manifes-
tations of atherothrombotic stroke [19J. Likewise, measurements of 
cutaneous blood flow may be more sensitive than other indicators of 
atherogenesis. They have the added advantage of easy accessibility. 
30 
27.5 0 
25 
8 
<J) 22.5 Ol 
c 
'6 20 
'" 
I ...J I-
~ 17.5 :;: 
0 
= 15 
-0 
0 
0 12.5 
:0 
X- 10 
'" OJ 0-
7.5 
0 
9 l J -l- I J -l-0 0 0 
2.5 
a HTG Post treatment Control 
45 
40 0 
Q) 
2: 35 
" u 
'" V> c: 30 
0 
a. 
-' 1-V> 25 ~ 
'" .g 20 S :;: 0 15 0 l I Qj S .D co 10 I I ~ <{ + 
0 
0 0 
C HTG Post treatment Control 
The importance of the present work is that for the first time an 
improvement in skin microcirculation was observed following a 
reduction of TG serum levels by fibric acid derivatives. Deduction 
from the skin microcirculation to that of the heart muscle is tempt-
ing. Our study may provide an explanation for the improved life 
expectancy observed following a reduction ofTG blood levels [22]. 
In conclusion, hypertriglyceridemia induces a decreased cutane-
ous microcirculatory response to ischemia, revealing an impaired 
preparedness of the vessels to adapt to changing circulatory require-
ments. The impaired vasodilatation may arise from several mecha-
nisms, including functional abnormalities of the endothelium or 
vascular smooth muscle, or structural changes in the blood vessels 
that limit vasodilatation. T hese changes are partly reversible, and 
corrected when reducing the triglyceride levels, but other changes 
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Figure 1. The measured parameters plotted according to group. (a) peak fl ow; b) time to peak; c) area under the response-time curve; d) time to decay. 
In this box plot the end of the upper tai l indicates the 90th percentile value. the Ilpper limit of the box the 75th percentile value. the solid line through the box the 
50th percentile value, the lower limit of the box the 25th percentile value. and the end of the lower tail rhe 10th percenrile va lue. For significance. see Results. 
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are persistent, indicating permanent damage. Dynamic measure-
ments of cutaneous blood flow are sensitive indicators of atherogen-
esis, and can be employed for the evaluation of microvascular in-
volvement in other organs. As the role of hypertriglyceridemia in 
atherosclerosis is uncovered, the noninvasive method presented 
may prove useful for the detection and foHow-up of such distur-
bances on an individual basis. 
The Ileip oj Drs. Binyami" Dorfman, Rodica Avram, and Sheila Oren-Vulfs is 
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